Browsing by Author Navid Shomali

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Dec-2022Cancer combination therapies by angiogenesis inhibitors; a comprehensive reviewMohammad Javed Ansari; Dmitry Bokov; Alexander Markov; Abduladheem Turki Jalil; Mohammed Nader Shalaby; Wanich Suksatan; Supat Chupradit; Hasan S. AL-Ghamdi; Navid Shomali; Amir Zamani; Ali Mohammadi; Mehdi Dadashpour
1-Dec-2022Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progressHendrik Setia Budi; Firdaus Nuri Ahmad; Harun Achmad; Mohammad Javed Ansari; Maria Vladimirovna Mikhailova; Wanich Suksatan; Supat Chupradit; Navid Shomali; Faroogh Marofi
1-Dec-2022Hurdles to breakthrough in CAR T cell therapy of solid tumorsFaroogh Marofi; Harun Achmad; Dmitry Bokov; Walid Kamal Abdelbasset; Zeid Alsadoon; Supat Chupradit; Wanich Suksatan; Siavash Shariatzadeh; Zahra Hasanpoor; Mahboubeh Yazdanifar; Navid Shomali; Farhad Motavalli Khiavi
1-Aug-2022Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advancesMarzieh Nikoo; Mohammad Rudiansyah; Dmitry Olegovich Bokov; NurlanĀ T Jainakbaev; Wanich Suksatan; Mohammad Javed Ansari; Lakshmi Thangavelu; Supat Chupradit; Amir Zamani; Ali Adili; Navid Shomali; Morteza Akbari
1-Dec-2022Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and consAdel Naimi; Rebar N. Mohammed; Ahmed Raji; Supat Chupradit; Alexei Valerievich Yumashev; Wanich Suksatan; Mohammed Nader Shalaby; Lakshmi Thangavelu; Siavash Kamrava; Navid Shomali; Armin D. Sohrabi; Ali Adili; Ali Noroozi-Aghideh; Ehsan Razeghian